Skip to main content
OpenTrials
Completed

NCT Number: NCT04594486

Medical Treatment for Acute Appendicitis

Medical treatment for acute appendicitis

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Uşak University

Uşak, 64200, Turkey (Türkiye)

About this study

Patients with clinically and radiologically approved acute appendicitis will be treated medically. The main aim of the study is to define the long term results of medical treatment for acute appendicitis. Patients will be followed by clinical visits and recurrences will be recorded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • clinically and radiologically approved acute appendicitis
  • approved and signed the informed consent form

Exclusion criteria

  • perforated cases
  • cases with peritonitis
  • patient wish for surgical treatment
  • allergy to drugs used in medical treatment of acute appendicitis

Treatment and study plan

Medical treatment of acute appendicitis

Other

All cases will be treated medically and will be followed for recurrences

Primary outcomes

  1. recuurence

    Time frame: 5 years

    recuurent acute appendicitis

Sponsors and collaborators

Lead sponsor

Uşak University

Other

Registry information

Official study title

Long Term Results of Medical Treatment for Acute Appendicitis

Important dates

Study start
2017
Primary completion
2023
Study completion
2024
First posted
Oct 20, 2020
Registry last updated
Mar 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.